Staging exocrine pancreatic dysfunction

Pancreatology ◽  
2021 ◽  
Author(s):  
Anam Khan ◽  
Santhi Swaroop Vege ◽  
Vikas Dudeja ◽  
Suresh T. Chari
1991 ◽  
Vol 154 (1) ◽  
pp. 45-48 ◽  
Author(s):  
Geoffrey J Cleghorn ◽  
Ristan Greer ◽  
Terence L Holt ◽  
Ross W Shepherd ◽  
John Erlich ◽  
...  

2005 ◽  
Vol 37 (12) ◽  
pp. 1345-1350 ◽  
Author(s):  
Martin Zenker ◽  
Julia Mayerle ◽  
Markus M Lerch ◽  
Andreas Tagariello ◽  
Klaus Zerres ◽  
...  

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. A379-A380
Author(s):  
Kaley N Breault ◽  
Brittney H Arakaki ◽  
Peminda K Cabandugama ◽  
Jordan M Rowe

Abstract Background: Currently there are no evidence-based medical recommendations to support the use of supplements in type 1 diabetes mellitus (DM), although there is some data that supports glucose lowering in type 2 DM with supplements such as cinnamon. Additionally, there is no evidence regarding the use of supplements in insulin-dependent DM secondary to pancreatic dysfunction from alcohol use disorder. Despite lack of clear evidence, it is estimated that more than 65% of Americans with DM use at least one dietary supplement for perceived health benefits. (1)Clinical Case: A 58-year old male presented with insulin-dependent DM secondary to pancreatic dysfunction from alcohol use disorder. Initial labs were significant for a low C-peptide of 0.13 ng/mL (0.80–3.85 ng/mL), A1c -9.4%, and blood glucoses ranging from 160–300 mg/dL. Patient’s DM regimen consisted of glargine 40 units nightly and aspart 12 units three times a day with meals. On a subsequent visit two months later, the patient stated that he had begun taking numerous supplements in hopes that these would improve his overall medical status. Supplements included Blood Boost Formula, Ultra K2 with MK-7, Chromium Picolinate, Male Enhancement, Super C Immune Complex, Nugenix Total-T, Niacinamide, Omega Q Plus Max, Cortisol Hormone Balancer, and Vitamin D3. Simultaneously, the patient self-discontinued all his maintenance medications except for his aforementioned insulin regimen due to the fear of negatively impacting his pancreas. Unexpectedly, his blood glucoses improved to a range of 90–150 mg/dL after being on these supplements without increasing his insulin dose. Upon literature review, three ingredients showed the most evidence for the possible explanation for his improvement in glucose control: L-arginine, nettle extract, and biotin with chromium. Conclusion: Literature review of in vivo and randomized, placebo-controlled studies demonstrated mechanisms of action for L-arginine, nettle extract, and biotin with chromium that indicate their potential role in lowering blood glucoses and increasing C-peptide levels in insulin-dependent DM secondary to pancreatic dysfunction from alcohol use disorder. Further investigations include exploring long-term impact on pancreatic function, glucose control, and insulin resistance. Reference: (1) Garrow, D., Egede, L. Association Between Complementary and Alternative Medicine Use, Preventive Care Practices, and Use of Conventional Medical Services Among Adults with Diabetes. Diabetes Care 2006 Jan; 29(1): 15–19.


2019 ◽  
Vol 15 (64) ◽  
pp. 328
Author(s):  
Veena Gadicherla ◽  
SivaReddy Challa ◽  
MandavaV Basaveswara Rao ◽  
PavanKumar Kunda ◽  
Ramakrishna Prudhvi

Amino Acids ◽  
2019 ◽  
Vol 51 (4) ◽  
pp. 727-738 ◽  
Author(s):  
Israelle Netto Freitas ◽  
Thiago dos Reis Araujo ◽  
Jean Franciesco Vettorazzi ◽  
Emily Amorim Magalhães ◽  
Everardo Magalhães Carneiro ◽  
...  

2012 ◽  
Vol 4 (3) ◽  
pp. 30 ◽  
Author(s):  
Shin-ichiro Hagiwara ◽  
Arata Watanabe

Shwachman-Diamond syndrome (SDS) is a rare, inherited, autosomal recessive disease characterized by exocrine pancreatic dysfunction, skeletal problems and varying degrees of cytopenias resulting in bone marrow dysfunction. We report the first case of SDS that was difficult to distinguish from celiac disease because this is a valuable example of the variety in SDS presentation.


1983 ◽  
Vol 29 (12) ◽  
pp. 2011-2018 ◽  
Author(s):  
A F Heeley ◽  
D Watson

Abstract We examine critically the biochemical methods capable of detecting and monitoring the end-organ disease processes in patients with cystic fibrosis. Although the diagnosis of cystic fibrosis is never justified on the basis of the sweat salt test alone, the original filter-paper technic (Gibson-Cooke, Pediatrics 23:545-549, 1959) for determining Na+ and Cl- concentrations in sweat remains the most discriminating method. We discuss the contributions for neonatal screening of the so-called cystic fibrosis protein, associated decreased enzymic activities in the homo- and heterozygous state, and immunoreactive trypsin. Because evidence of either intestinal malabsorption or a pancreatic lesion must be sought, we review the use and interpretation of some tests of pancreatic dysfunction (meconium albumin, duodenal juice components, serum pancreatic isoamylase, and trypsinogen), both in establishing and in confirming the diagnosis of cystic fibrosis.


Sign in / Sign up

Export Citation Format

Share Document